Sarcoma.

1 Phase 1 study recruiting right now, most recently updated first.

Sarcoma1 study

RhabdomyosarcomaNCT06865664Papers

FGFR4-CAR T Cells

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

National Cancer Institute (NCI)Open the brief

Phase 1 — first-in-human trials, explained